Evidence map›Paper›PMID 41692852›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Time-robust myocardial [

Song Xue, Qianling Ye, Aleksa Lazarević, Kevin Hamzaraj, Patrick Binder, Christian Nitsche, Attila Kiss, Bruno K Podesser, Marcus Hacker, Xiang Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Song XueDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
Qianling YeLudwig Boltzmann Institute for Cardiovascular Research, Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.
Aleksa LazarevićDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
Kevin HamzarajDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Patrick BinderDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
Christian NitscheDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Attila KissLudwig Boltzmann Institute for Cardiovascular Research, Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.
Bruno K PodesserLudwig Boltzmann Institute for Cardiovascular Research, Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
Xiang LiDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. Xiang.li@meduniwien.ac.at.ORCID 0000-0002-0016-6233
Raffaella CalabrettaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAortic stenosis (AS) induces myocardial remodeling and fibroblast activation, yet modifiable biomarkers capable of capturing active fibrogenesis and predicting post-transcatheter aortic valve implantation (TAVI) recovery are currently scarce. Fibroblast activation protein (FAP)-targeted PET serves as a noninvasive tool to visualize activated fibroblasts in vivo. We evaluated a time-robust, blood-pool-normalized myocardial [

methodsNineteen patients with severe symptomatic AS underwent [

resultsBlood-pool SUV

conclusionsMyocardial [

Indexed as

Aortic Valve StenosisGelatinasesPositron Emission Tomography Computed TomographySerine EndopeptidasesTranscatheter Aortic Valve ReplacementAgedAged, 80 and overBiomarkersEndopeptidasesFemaleFibroblast Activation Protein AlphaGallium RadioisotopesHumansMaleMyocardiumPrognosis68Ga-FAPIBiomarkersEndopeptidasesFibroblast Activation Protein AlphaGallium RadioisotopesGelatinasesQuinolinesSerine Endopeptidases[68Ga]Ga-FAPI PETAortic stenosisImaging biomarkerMyocardial fibrosisTAVI

Identifiers

PMID41692852
PMCPMC13121330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.